Novartis is stopping the development of ianalumab in hidradenitis suppurativa (HS) after a Phase IIb proof-of-concept trial ...

Pharmaceutical companies and manufacturers, including MilliporeSigma (Burlington, US), Simtra BioPharma Solutions (Parsippany, US), Carbogen AMCIS (Bubendorf, Switzerland), and BioNTech (Mainz, ...

"Government subsidies drive China’s vehicle market up – GlobalData" was originally created and published by Just Auto, a ...

Localising and automating supply chains will allow companies to mitigate the impact of tariffs and minimise resulting costs.

Investors should have a “keep calm and carry on” approach to financial markets, maintaining a long position in emerging market FX carry trades, said Daniel von Ahlen, senior macro strategist at ...

Following today’s release of DFS’ figures for the 52 weeks ending 29 June 2025; Matt Walton, senior retail analyst at ...

Walmart and its banking partner Mastercard have created a new payment system for international money transfers, data ...

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into ...